Vannini, Eleonora <br/><br/>
Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages.  [electronic resource] 

 -  Oncotarget  Apr 2017 
 - 23539-23550 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.15328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Bacterial Toxins--pharmacology<br/>Blotting, Western<br/>Brain--drug effects<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Disease Progression<br/>Disks Large Homolog 4 Protein<br/>Escherichia coli Proteins--pharmacology<br/>Glioma--drug therapy<br/>Guanylate Kinases--metabolism<br/>Humans<br/>Membrane Proteins--metabolism<br/>Mice, Inbred C57BL<br/>Motor Activity--drug effects<br/>Motor Disorders--drug therapy<br/>Time Factors<br/>Tumor Burden--drug effects